BRIEF published on 05/08/2026 at 06:35, 8 hours 43 minutes ago Lonza annonce de solides résultats au premier trimestre 2026 et confirme ses perspectives annuelles. Expansion Opérationnelle Stratégie De Désinvestissement Lonza T1 2026 Croissance Des CDMO Résilience Géopolitique
BRIEF published on 05/08/2026 at 06:35, 8 hours 43 minutes ago Lonza Reports Strong Q1 2026 Performance, Affirms Annual Outlook Operational Expansion CDMO Growth Divestment Strategy Lonza Q1 2026 Geopolitical Resilience
PRESS RELEASE published on 05/08/2026 at 06:30, 8 hours 48 minutes ago Lonza Delivers Strong Performance in Q1 2026 in Line with Expectations and Confirms Full-Year Outlook 2026 Lonza delivers strong performance in Q1 2026, confirms outlook for the year. Completes transformation to a pure-play CDMO CDMO Lonza Outlook Transformation Q1 2026
BRIEF published on 04/01/2026 at 06:35, 1 month 7 days ago Lonza annonce les détails de son assemblée générale annuelle 2026 et publie ses rapports 2025. Proposition De Dividende Changements Au Conseil D'administration Efforts De Développement Durable Rapport Annuel 2025 Assemblée Générale Annuelle De 2026
BRIEF published on 04/01/2026 at 06:35, 1 month 7 days ago Lonza Announces 2026 AGM Details and Publishes 2025 Reports Board Changes Dividend Proposal Sustainability Efforts 2025 Annual Report 2026 AGM
PRESS RELEASE published on 04/01/2026 at 06:30, 1 month 7 days ago Lonza Publishes 2026 Annual General Meeting Invitation and 2025 Annual and Sustainability Reports Lonza publishes 2026 AGM invitation and 2025 Annual and Sustainability Reports. Board changes and dividend increase announced Dividend Increase Lonza Annual Report Sustainability Report 2026 AGM
BRIEF published on 03/31/2026 at 14:05, 1 month 8 days ago Lonza Nominates Stephen Fry as Independent Board Member Pharmaceutical Industry Governance Organizational Transformation Lonza Board Stephen Fry
BRIEF published on 03/31/2026 at 14:05, 1 month 8 days ago Lonza nomme Stephen Fry membre indépendant du conseil d'administration Gouvernance Industrie Pharmaceutique Transformation Organisationnelle Conseil D'administration De Lonza Stephen Fry
PRESS RELEASE published on 03/31/2026 at 14:00, 1 month 8 days ago Lonza Nominates Stephen Fry as Independent Board Member Lonza nominates Stephen Fry, with extensive pharma industry track record, as Independent Board Member. Fry to join Lonza AGM in May 2026 Lonza AGM Board Member Pharma Industry Stephen Fry
BRIEF published on 03/09/2026 at 14:05, 1 month 30 days ago Lonza and Genetix Extend Manufacturing Agreement for ZYNTEGLO™ Lonza Gene Therapy Manufacturing Agreement Genetix ZYNTEGLO™
Published on 05/08/2026 at 15:00, 18 minutes ago Jaguar Health Regains Compliance with Nasdaq's Publicly Held Shares Requirement and Receives Additional Extension, Until May 18, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule
Published on 05/08/2026 at 14:55, 23 minutes ago Nepra Foods Inc. to Present at the 16th Annual LD Micro Invitational
Published on 05/08/2026 at 14:30, 48 minutes ago Unusual Machines Hosts Live Drone Ecosystem Demonstrations at XPONENTIAL 2026
Published on 05/08/2026 at 14:00, 1 hour 18 minutes ago BlackBerry Announces Renewal of Normal Course Issuer Bid Share Buyback Program
Published on 05/08/2026 at 14:00, 1 hour 18 minutes ago Loop Industries to Host Fourth Quarter 2025 Earnings Conference Call
Published on 05/08/2026 at 15:08, 10 minutes ago Siltronic AG's Annual General Meeting approves all agenda items by a clear majority
Published on 05/08/2026 at 13:53, 1 hour 25 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/08/2026 at 13:35, 1 hour 43 minutes ago DeFi Technologies Announces Partnership with OMFIF's Digital Monetary Institute and Confirms Participation at the Digital Money Summit 2026 in London
Published on 05/08/2026 at 13:05, 2 hours 13 minutes ago Philadelphia Soccer 2026 Opens Media Credentialing and Fan Registration for FIFA Fan Festival™ Philadelphia
Published on 05/07/2026 at 19:15, 20 hours 3 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 20 hours 3 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 20 hours 12 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 20 hours 12 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 20 hours 18 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
